The answer to that question seems to be yes, and the impact may be influenced by the timing of the biopsy or curettage, according to the results of a Cochrane Collaboration review.
The answer to that question seems to be yes, and the impact may be influenced by the timing of the biopsy or curettage, according to the results of a Cochrane Collaboration review. The researchers analyzed 5 randomized controlled trials (RCT) comparing intentional endometrial injury before embryo transfer in women undergoing assisted reproduction with no intervention or with a simulated procedure that could not cause endometrial injury.
In 4 of the trials, endometrial injury was performed within 1 month before the start of ovulation induction, whereas in the fifth trial, it was performed on the day of oocyte retrieval. Analysis of these 2 subgroups showed a significant increase in odds of live birth and clinical pregnancy for injury in the previous cycle (2 trials, Peto OR 2.45; 95% CI 1.28 to 4.72; I2 = 0% and 4 trials, Peto OR 2.51; 95% CI 1.71 to 3.97; 12 = 0, respectively). In contrast, injury on the day of oocyte retrieval was associated with a significant reduction in odds of clinical pregnancy (1 trial, Peto OR 0.30; 95% CI 0.14 to 0.63) and of ongoing pregnancy (1 trial, Peto OR 0.28; 95% CI 0.13 to 0.61). No meaningful conclusions could be drawn about odds of miscarriage per clinical pregnancy or multiple pregnancy per clinical pregnancy.
In women undergoing assisted reproduction, the Cochrane researchers concluded, endometrial injury should done before the embryo transfer cycle because it increases clinical pregnancy and live birth rates. Evidence is insufficient, however, to determine the effect of the procedure on rates of multiple pregnancy or miscarriage.
Commentary: This Cochrane review demonstrated a benefit (increased clinical pregnancy and live birth rates) from endometrial injury in women undergoing ART. The timing of this low-grade endometrial injury is important, with a deleterious effect noted if injury is performed within 3 days of the embryo transfer. While these are compelling findings, they must be regarded with caution in light of a conservative number of observed events, as only 50 live births were reported.
–Laurie McKenzie, MD
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More